Insider Cluster (3 insiders) ·Filed Sep 3, 2026

TDOC

Teladoc Health, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed28d 18h ago
Insider cluster: 2 insiders, $163K total
Actionable Insight • Neutral

The insider selling is too small to warrant a bearish read. Monitor Teladoc's next quarterly filing for revenue/earnings trends and any guidance changes — the stock has been volatile and past cluster reports on TDOC have shown strong positive drift, but this particular cluster lacks conviction. No immediate trade signal.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
TDOC ▲ +3.50% at T+5d
NEUTRAL call ✓ call won +3.50% · α vs SPY +4.71% · entry $6.28 → $6.50
Next anchor: T+20d due 14h ago
Latest observation: T+18 +10.24% FF3 residual α
Entry anchored
Sep 3, 04:00 PM ET
via 1-min bar
T+1d
-0.32%
call -0.32% · α +0.23%
$6.26
settled 29d ago
T+5d
+3.50%
call +3.50% · α +4.71%
$6.50
settled 22d ago
T+20d
—
call — · α —
—
due 14h ago
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

CEO Charles Divita and CLO Adam Vandervoort sold a combined $163K in open-market shares at ~$6.30 on September 2, 2026. The total value represents only 0.014% of Teladoc's $1.2B market cap — a trivial amount that does not signal material insider concern. Non-cash derivative exercises and a CFO grant also occurred on September 1 but carry no economic significance.

Key Financial Metrics

Direction
selling
Total Value
$163.0K
Insiders
3

Key Facts

  • CEO Divita sold 18,327 shares for $115K on 2026-09-02
  • CLO Vandervoort sold 7,573 shares for $48K on 2026-09-02
  • Total open-market sales: $163K, or 0.014% of $1.2B market cap
  • Non-cash events: Vandervoort exercised 29,856 derivative shares at $0; Divita exercised 88,486 derivative shares at $0; CFO Grasher received a 239,616-share grant at $0
  • No 10b5-1 plan or regular pattern detected — sales appear opportunistic but immaterial

Financial Impact

Insider sales of $163K are negligible relative to $1.2B market cap

dilutioninsider ownership

Risk Factors

  • CEO and CLO both sold on the same day, which could be perceived negatively by momentum traders despite the small size
  • Non-cash derivative exercises increase share count modestly, but the grant to the CFO adds 239,616 shares to potential dilution

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
35% bullish (31 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TDOC-1788505868878
17 reports for TDOC
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +11.92%Aug 7, 2026
Filters
Rows
Reports for TDOC — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
144
NEUTRAL ★ 2/10
$6.16 $6.30▲ +2.27%▲ +2.49%$5.52 (−10.39%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$6.28 $6.50▲ +3.50%▲ +4.71%$5.52 (−12.10%)
Sep 2, 2026
4w ago
144
NEUTRAL ★ 2/10
$6.46 $6.09▼ −5.73%▼ −4.77%$5.52 (−14.55%)
Aug 7, 2026
8w ago
Press Release
BEARISH ★ 8/10
$7.13 $6.81▲ +4.49%▲ +4.89%$5.52 (+22.58%)
Jul 31, 2026
9w ago
Press Release
BEARISH ★ 8/10
$6.68 $7.08▼ −5.99%▼ −3.96%$5.52 (+17.37%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 2/10
$8.69 $9.29▲ +6.90%▲ +5.52%$5.52 (−36.48%)
Jun 11, 2026
16w ago
144
NEUTRAL ★ 2/10
$7.31 $7.59▲ +3.83%▲ +3.40%$5.52 (−24.49%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$7.31 $7.59▲ +3.83%▲ +3.40%$5.52 (−24.49%)
Jun 2, 2026
17w ago
144
NEUTRAL ★ 2/10
$7.09 $7.03▼ −0.85%▲ +2.97%$5.52 (−22.14%)
Jun 2, 2026
17w ago
144
NEUTRAL ★ 2/10
$7.09 $7.03▼ −0.85%▲ +2.97%$5.52 (−22.14%)
Showing 10 of 17

US Market Status

Market Closed — Opens Mon (35h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 4, 2026